Enforced expression of p210bcr-abl transforms interleukin 3 (IL-3)-dependent hematopoietic cell lines to growth factor-independent proliferation. It has been demonstrated that nonreceptor tyrosine kinase oncogenes may couple to the p21ras pathway to exert their transforming effect. In particular, p210bcr-abl was recently found to effect p21ras activation in hematopoietic cells. In this context, experiments were performed to evaluate a protein signaling pathway by which p210bcr-abl might regulate p21ras. It was asked whether Shc p46/p52, a protein containing a src-homology region 2 (SH2) domain, and known to function upstream from p21ras, might form specific complexes with p210bcr-abl and thus, possibly alter p21ras activity by coupling to the guanine nucleotide exchange factor (Sos/CDC25) through the Grb2 protein-Sos complex. This latter complex has been previously demonstrated to occur ubiquitously. We found that p210bcr-abl formed a specific complex with Shc and with Grb2 in three different murine cell lines transfected with a p210bcr-abl expression vector. There appeared to be a higher order complex containing Shc, Grb2, and bcr-abl proteins. In contrast to p210bcr-abl transformed cells, in which there was constitutive tight association between Grb2 and Shc, binding between Grb2 and Shc was Steel factor (SLF)-dependent in a SLF-responsive, nontransformed parental cell line. The SLF-dependent association between Grb2 and Shc in nontransformed cells involved formation of a complex of Grb2 with c-kit receptor after SLF treatment. Thus, p210bcr-abl appears to function in a hematopoietic p21ras activation pathway to allow growth factor-independent coupling between Grb2, which exists in a complex with the guanine nucleotide exchange factor (Sos), and p21ras. Shc may not be required for Grb2-c-kit interaction, because it fails to bind strongly to c-kit.
Article|
January 01 1994
Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
T Tauchi,
T Tauchi
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
H S Boswell,
H S Boswell
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
D Leibowitz,
D Leibowitz
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
H E Broxmeyer
H E Broxmeyer
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
Search for other works by this author on:
T Tauchi
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
H S Boswell
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
D Leibowitz
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
H E Broxmeyer
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1994) 179 (1): 167–175.
Citation
T Tauchi, H S Boswell, D Leibowitz, H E Broxmeyer; Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.. J Exp Med 1 January 1994; 179 (1): 167–175. doi: https://doi.org/10.1084/jem.179.1.167
Download citation file: